O. Yazici Et Al. , "The importance of thiol/disulphide homeostasis in patients with advanced gastric cancer (AGC) receiving modified docetaxel and cisplatin plus fluorouracil (mDCF) regimen," European Cancer Congress , vol.51, Vienna, Austria, 2015
Yazici, O. Et Al. 2015. The importance of thiol/disulphide homeostasis in patients with advanced gastric cancer (AGC) receiving modified docetaxel and cisplatin plus fluorouracil (mDCF) regimen. European Cancer Congress , (Vienna, Austria).
Yazici, O., Ozdemir, N., Erel, O., Demirci, N. S., Aksoy, S., Sendur, M. A. N., ... Dogan, M.(2015). The importance of thiol/disulphide homeostasis in patients with advanced gastric cancer (AGC) receiving modified docetaxel and cisplatin plus fluorouracil (mDCF) regimen . European Cancer Congress, Vienna, Austria
Yazici, O. Et Al. "The importance of thiol/disulphide homeostasis in patients with advanced gastric cancer (AGC) receiving modified docetaxel and cisplatin plus fluorouracil (mDCF) regimen," European Cancer Congress, Vienna, Austria, 2015
Yazici, O. Et Al. "The importance of thiol/disulphide homeostasis in patients with advanced gastric cancer (AGC) receiving modified docetaxel and cisplatin plus fluorouracil (mDCF) regimen." European Cancer Congress , Vienna, Austria, 2015
Yazici, O. Et Al. (2015) . "The importance of thiol/disulphide homeostasis in patients with advanced gastric cancer (AGC) receiving modified docetaxel and cisplatin plus fluorouracil (mDCF) regimen." European Cancer Congress , Vienna, Austria.
@conferencepaper{conferencepaper, author={O. Yazici Et Al. }, title={The importance of thiol/disulphide homeostasis in patients with advanced gastric cancer (AGC) receiving modified docetaxel and cisplatin plus fluorouracil (mDCF) regimen}, congress name={European Cancer Congress}, city={Vienna}, country={Austria}, year={2015}}